Amneal Pharmaceuticals

Latest Medical Stock News

FILTER BY TOPIC:     Medical Devices   Diagnostics & Research   Medical Distribution   Psychedelics        List of All Medical Stocks  

Illumina launches new software to enable tertiary analysis for oncology applications, and soon rare disease

March 27
Last Trade: 217.75 -2.25 -1.02

As demand for clinical next-generation sequencing grows, Illumina Connected Insights enables user to streamline data interpretation and report generation to inform precision care SAN DIEGO, March 27, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the release of Connected Insights, a new cloud-based software enabling tertiary analysis for clinical...Read more


Syneos Health Launches Medical Affairs Digital Amplifier

March 27
Last Trade: 34.82 0.30 0.87

MORRISVILLE, N.C., March 27, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the launch of Medical Affairs Digital Amplifier, a program designed to drive smarter and more effective scientific exchange. This integrated program seeks to ensure customers, and the clinicians they serve, have access to the latest education to optimize patient...Read more


Delcath Systems Announces FDA Acceptance of New Drug Application Resubmission of Hepzato Kit with a PDUFA Date of August 14, 2023

March 27
Last Trade: 5.70 0.86 17.77

NEW YORK, March 27, 2023 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced that the US Food and Drug Administration (FDA) has accepted Delcath Systems, Inc.'s (Delcath) new drug application resubmission for HEPZATO™ Kit (melphalan hydrochloride for Injection/Hepatic Delivery System) seeking approval for the treatment...Read more


DarioHealth Selected as Digital Therapeutics Partner by a Top-Ten Digitally Enabled Pharmacy Benefits Manager

March 27
Last Trade: 4.15 0.08 1.84

New agreement is the first contract resulting from strategic partnership with Sanofi NEW YORK, March 27, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital therapeutics (DTx) market, announced a new contract with a leading nationwide Pharmacy Benefits Manager (the "PBM") operating in 50 states to provide Dario's digital therapeutics, starting with the diabetes solution, to...Read more


G Medical Innovations And Micare Path Announce Joint Collaboration To Provide Innovative Remote Patient Monitoring Solutions Globally

March 27
Last Trade: 2.09 0.11 5.56

Rehovot, Israel, March 27, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company” or “G Medical Innovations”), a global leader in next-generation mobile health (mHealth) and digital health, and MiCare Path, a leader in optimized patient care through remote patient monitoring, today announced a collaboration to incorporate MiCare Path’s solutions and G Medical Innovations’ solutions. As part of the...Read more


Genetic Technologies: GeneType Multi-Risk Test now includes Melanoma, Pancreatic Cancer & Atrial Fibrillation

March 27
Last Trade: 1.16 0.06 5.45

MELBOURNE, Australia, March 27, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) – a global leader in genomics-based tests in health, wellness and serious disease – is pleased to announce the US launch of three (3) new diseases taking the total number of individual risk assessments included in the geneType Multi-Test to nine (9), all from the one simple saliva sample. This launch is in line...Read more


Petvivo Holdings To Exhibit At The IVAPM Pain Management Forum In Atlanta, Georgia 

March 27
Last Trade: 2.97 0.0026 0.09

MINNEAPOLIS, March 27, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets announced today it is a Platinum Sponsor and will be exhibiting at the International Veterinary Academy of Pain Management (“IVAPM”) Pain Management Forum to be held April 2nd to April 4th 2023 at the Westin Peachtree...Read more


Delcath Systems Announces up to $85 Million Financing

March 27
Last Trade: 5.70 0.86 17.77

Led by Vivo Capital with participation from Logos Capital, BVF Partners LP, Stonepine Capital Management, LLC, Serrado Capital LLC and supported by existing investor, Rosalind Advisors $25 million financing upfront with up to an additional $60 million tied to satisfaction of milestones Aggregate financing expected to be sufficient to fund Company through potential approval of HEPZATO and commercialization NEW YORK, March 27, 2023...Read more


BioSig Technologies Announces New Advisory Board Member Edwin Wang

March 27
Last Trade: 1.13 0.01 0.89

Westport, CT, March 27, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP™ System, today announced the appointment of new Advisory Board member Edwin Wang. Mr. Wang has over 20 years of impactful experience in private...Read more


Delcath Systems Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update

March 27
Last Trade: 5.70 0.86 17.77

NEW YORK, March 27, 2023 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported business highlights and financial results for the fourth quarter and full year ended December 31, 2022. Recent Business Highlights During and since the fourth quarter, Delcath Systems, Inc. (Delcath or the Company): Received an...Read more


Medigus: Viewbix Reports its Financial Results for 2022 with a 114% Growth in Revenues Totaling $97 Million

March 27
Last Trade: 4.26 0.11 2.65

Viewbix is a subsidiary of Gix Internet whose results are consolidated with Medigus’ financial statements Tel Aviv, Israel, March 27, 2023 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that Viewbix Inc. (henceforth “Viewbix”) (OTC: VBIX), 76% owned by Medigus’ subsidiary Gix...Read more


Venus Concept Announces Fourth Quarter and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Revenue Guidance

March 27
Last Trade: 0.18 -0.0078 -4.15

TORONTO, March 27, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and twelve months ended December 31, 2022. Fourth Quarter 2022 Summary & Recent Highlights: Total revenue of $24.3 million, down $8.3 million, or 26%, year-over-year; up $2.7 million, or 13% quarter-over-quarter. U.S. revenue...Read more


Nexalin Technology Provides 2022 Year-End Business Update

March 27
Last Trade: 1.03

HOUSTON, March 27, 2023 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today provided a business update for the year ended December 31, 2022. Mark White, CEO of Nexalin Technology stated, “Nexalin has made significant progress towards commencing clinical trials of our Gen-2 and Gen-3 neurostimulation devices in the United States. Nexalin’s enhanced neurostimulation devices combine...Read more


Enrollment Begins in FORESEE Clinical Trial Using Biocept’s CNSide™ to Evaluate Patients with Leptomeningeal Metastases

March 24
Last Trade: 0.30 0.0031 1.06

SAN DIEGO / Mar 24, 2023 / Business Wire / Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces enrollment of the first patient in the FORESEE clinical trial with the Company’s proprietary cerebrospinal fluid assay CNSide (NCT05414123). This first patient was seen at the UT Southwestern Medical Center, one of the largest and most respected hospitals in the nation. The FORESEE...Read more


BioSig Technologies Announces New Advisory Board Member Lorraine Spurge

March 24
Last Trade: 1.13 0.01 0.89

Westport, CT, March 24, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP™ System, today announced the appointment of Lorraine Spurge, entrepreneur and financier, to its Advisory Board. As founder and CEO of Maple Stone...Read more


Spectral Medical Announces Fourth Quarter and Fiscal 2022 Results and Provides Corporate Update

March 24
Last Trade: 0.32

Reports significant enhancements to accelerate Tigris patient enrollment including appointment of new Contract Research Organization Management to host Investor Day on April 6, 2023 TORONTO, March 24, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the fourth...Read more


electroCore Reports Results of Pre-Clinical Trial in a Model of Traumatic Brain Injury

March 23
Last Trade: 5.41 0.07 1.31

ROCKAWAY, N.J., March 23, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the publication of a paper entitled “Non-Invasive Vagus Nerve Stimulation Improves Brain Lesion Volume and Neurobehavioral Outcomes in a Rat Model of Traumatic Brain Injury” in the peer-reviewed Journal of Neurotrauma. The lead author is Dr. Afshin Divani of...Read more


New evidence demonstrates Smith+Nephew's COBLATION™ Technology can accelerate patient recovery with fewer complications compared with total tonsillectomy techniques

March 23
Last Trade: 28.05 0.25 0.90

LONDON, March 23, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces results from new scientific research that shows its COBLATION Intracapsular Tonsillectomy (CIT) technique can lead to improved post-operative outcomes in patients versus total tonsillectomy techniques. The research was recently published online by OTO Open: The Open Access Journal of the American Academy of...Read more


Establishment Labs Announces First Mia Femtech™ Partners in Europe and Second Partner Chain in Japan

March 23
Last Trade: 70.89 -0.06 -0.08

NEW YORK / Mar 23, 2023 / Business Wire / Establishment Labs Holdings Inc. (Nasdaq: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it has entered into agreements with four partners in Europe and a second partner chain in Japan for Mia Femtech™ (“Mia®”). “Our global rollout of Mia Femtech continues, and we are pleased to...Read more


TELA Bio Announces 510(k) Clearance for OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery

March 23
Last Trade: 10.11 0.06 0.60

MALVERN, Pa., March 23, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy, today announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the Company's OviTex PRS Long-Term Resorbable product. OviTex PRS...Read more


ZimVie’s Exclusive Puros® Cancellous Particulate Allograft Dental Bone Grafting Solution Excels in Landmark Comparative Study in The International Journal of Oral & Maxillofacial Implants

March 23
Last Trade: 6.31 0.11 1.77

WESTMINSTER, Colo., March 23, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the publication of an article titled Comparison of the Effects of Tissue Processing on the Physicochemical Properties of Bone Allografts in The International Journal of Oral & Maxillofacial Implants. ZimVie Dental’s Puros Cancellous Particulate Allograft bone substitute was...Read more


Therma Bright Prepares Launch of Digital Cough Screening and Data Collection Smartphone Application

March 23
Last Trade: 0.07 0.005 7.69

Toronto, Ontario--(Newsfile Corp. - March 23, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer and investor in a range of leading-edge, proprietary diagnostic and medical device technologies, is pleased to announce that the Company and AI4LYF are preparing to launch DCT, its digital cough data collection and screening smartphone application. On February 16, 2023, Therma Bright announced that...Read more


T2 Biosystems Affirms Plans to Add Candida Auris Detection to the FDA-Cleared T2Candida Panel

March 23
Last Trade: 0.48 -0.02 -3.98

LEXINGTON, Mass., March 23, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today affirmed plans to add detection of the fungal pathogen Candida auris to the Company’s FDA-cleared and CE marked T2Candida® Panel. According to a March 21, 2023 Wall Street Journal report, Candida auris is a multidrug-resistant pathogen labeled by...Read more


Avricore Health’s HealthTab™ Passes 530 Locations, Adds Virus Detection

March 23
Last Trade: 0.31 0.005 1.64

VANCOUVER, British Columbia, March 23, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) continues to grow the HealthTab™ network of pharmacy locations, reaching 532 locations. In 100 of these locations, the Company will be deploying Abbott’s ID Now™, either in combination with the Afinion 2™ or standalone, to support virus detection and assess the demand and effectiveness of infectious disease screening...Read more


Trinity Biotech Announces Fourth Quarter and Fiscal Year 2022 Financial Results

March 23
Last Trade: 0.88 -0.06 -6.10

DUBLIN, Ireland, March 23, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended December 31, 2022 and fiscal year 2022. Summary Highlights Revenue: Total revenues for fiscal year 2022 and Q4, 2022 were $74.8m and $18.0m respectively. Excluding our Covid focused PCR...Read more


CareDx Presents Latest Advancements at 12th Congress of the International Pediatric Transplant Association

CareDx to Host Symposium Featuring the Latest Developments in Pediatric Transplant Care BRISBANE, Calif. / Mar 23, 2023 / Business Wire / CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced its gold-level sponsorship and participation at the...Read more


Henry Schein to Host Pre-conference Program at the 2023 ADSO Annual Summit

March 23
Last Trade: 79.70 0.53 0.67

Program to Feature a Panel Discussion with Company CEO Stanley Bergman and Jeannie Diefenderfer, CEO of the Higher Ambition Leadership Alliance MELVILLE, N.Y. / Mar 23, 2023 / Business Wire / In collaboration with the Association of Dental Support Organizations (ADSO), Henry Schein, Inc. (Nasdaq: HSIC) today announced that it will present a pre-conference program on Tuesday, March 28 from 2:30 – 5:30 pm at the 2023 ADSO Annual...Read more


Nyxoah Announces a $15 Million Private Placement Financing

March 23
Last Trade: 7.17 0.16 2.28

Mont-Saint-Guibert, Belgium – March 23, 2023, 9:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced a €13.35 million private placement financing from the sale of 2,047,544 new ordinary shares at a price per share of €6.52...Read more


MIMEDX Announces Chief Financial Officer Transition

March 23
Last Trade: 3.40 0.01 0.29

MARIETTA, Ga., March 23, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a pioneer and leader in placental biologics, today announced that Peter M. Carlson, Chief Financial Officer, has decided to leave the Company to pursue other opportunities. The Company has initiated a search for its next Chief Financial Officer and Mr. Carlson will be assisting MIMEDX throughout this process to ensure a smooth...Read more


Beyond Air® Appoints Jeff Myers, M.D. Ph.D. as Chief Medical Officer

March 23
Last Trade: 6.24 0.10 1.63

GARDEN CITY, N.Y., March 23, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and, through its affiliate Beyond Cancer, Ltd., ultra-high concentration nitric oxide...Read more


Gerry O’Sullivan, the Latest Member to Join Microbot Medical’s Scientific Advisory Board, to Leverage Extensive Interventional Radiology Experience to Progress the LIBERTY® Robotic System Through Regulatory, Clinical and Commercialization Phases

Widely Published Interventional Radiologist Has Earned Well-Regarded Reputation Working with Prestigious Medical Centers in the U.S. and Europe The addition of Professor O’Sullivan, the Clinical Director of Radiology for the Galway Clinic in Ireland, Expands the Company’s EU Presence. HINGHAM, Mass., March 23, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) continues to receive global interest from interventional...Read more


ReShape Lifesciences Announces Formation of International Scientific Advisory Board

March 23
Last Trade: 2.89 -0.19 -6.22

SAN CLEMENTE, Calif., March 23, 2023 (GLOBE NEWSWIRE) --  ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced the formation of a Scientific Advisory Board (SAB). Members include internationally recognized experts and surgeons in the obesity and metabolic disease fields. The newly created SAB will provide management with strategic input and external...Read more


Eargo Reports Fourth Quarter 2022 Financial Results

March 23
Last Trade: 4.21 -0.07 -1.59

Recent Highlights: Net revenues of $12.9 million in the fourth quarter of 2022, compared to $10.1 million in the fourth quarter of 2021 and $7.9 million in the third quarter of 2022 Gross systems shipped of 8,863, compared to 7,767 in the fourth quarter of 2021 GAAP operating loss $23.9 million in the fourth quarter of 2022, compared to $45.2 million in the fourth quarter of 2021 and $26.0 million in the third quarter of 2022 Cash...Read more


Medtronic to boost AI innovation with new platform introduction

March 22
Last Trade: 80.21 0.84 1.06

A strategic collaboration with Cosmo Pharmaceuticals  and NVIDIA delivers the GI Genius™ AI Access™ platform designed to accelerate AI innovation for healthcare. DUBLIN, March 22, 2023 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced Cosmo Pharmaceuticals and NVIDIA plan to integrate NVIDIA's AI technologies into the GI Genius™ intelligent endoscopy module — the first...Read more


Bionano Genomics Announces First Study Using OGM to Discover Structural Variants with Potential Relevance to Genetic Diagnosis of MRKH Syndrome, a Syndrome Impacting Reproductive System Development in 1 in 4,500 Females

March 22
Last Trade: 1.11 0.01 0.91

Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome is among several forms of Müllerian agenesis, a disorder impacting 1 in 4,500 females which is indicated by the absence or underdevelopment of the female reproductive system Researchers in the study hypothesized that a genome-wide structural variant (SV) analysis would result in the identification of rare SVs relevant to MRKH’s genetic etiology, which might lead to better understanding of...Read more


Syneos Health and KX Partner to Pioneer Data-Driven Transformation in Biopharmaceutical Asset Development

March 22
Last Trade: 34.82 0.30 0.87

MORRISVILLE, N.C., March 22, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with KX, maker of kdb, the world’s fastest time series database and analytics engine. The partnership will deliver data-driven predictive analytics, Artificial Intelligence (AI) and Machine Learning (ML) capabilities to help customers address...Read more


Quest Diagnostics Unveils Advanced Transplant Diagnostic Services Featuring Anywhere-Access in the United States

March 22
Last Trade: 139.64 -0.43 -0.31

New capabilities include personalized patient access to Quest's national network of 2,100 patient service centers and 5,000 mobile and at-home phlebotomists, to support patient-compliant pre- and post-transplant testing and nationwide access, regardless of surgical center location SECAUCUS, N.J., March 22, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today...Read more


Massive Bio and NeoGenomics Announce Collaboration to Accelerate Oncology Drug Discovery and Improve Patient Care

March 22
Last Trade: 17.37 0.50 2.96

Collaboration will leverage NeoGenomics’ large oncology diagnostic laboratory and Massive Bio’s proven-at-scale proprietary artificial intelligence platform to accelerate drug discovery and optimize patient selection for clinical trials. FT. MYERS, Fla. & NEW YORK / Mar 22, 2023 / Business Wire / Massive Bio, Inc., a private AI-enabled oncology startup that provides virtual and in-person concierge services for cancer patients, and...Read more


New Publication Demonstrates Utility of Natera’s Signatera™ Test in Melanoma

March 22
Last Trade: 56.15 -0.50 -0.88

Real-world findings from >550 plasma samples highlight prognostic and predictive value of Signatera for adjuvant decision-making and immunotherapy monitoring AUSTIN, Texas / Mar 22, 2023 / Business Wire / Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced a new study published in Cancer showing the prognostic and predictive utility of Natera’s personalized and tumor-informed molecular residual...Read more


Bausch + Lomb and Novaliq Announce Publication of Second Pivotal Phase 3 Data on NOV03 (Perfluorohexyloctane) in American Journal of Ophthalmology

March 22
Last Trade: 16.27 0.36 2.26

NOV03 Consistently Met Primary Endpoints for Signs and Symptoms of Dry Eye Disease Associated with Meibomian Gland Dysfunction NOV03 PDUFA Action Date is June 28, 2023 VAUGHAN, Ontario & HEIDELBERG, Germany / Mar 22, 2023 / Business Wire / Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and Novaliq GmbH, a biopharmaceutical...Read more


Nanox.AI Expands Footprint Through New Global Partnership with Ferrum Health

March 22
Last Trade: 5.82 0.12 2.11

NEVE ILAN, Israel, March 22, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging technology company, today announced that that its deep-learning medical imaging analytics subsidiary, Nanox.AI, has entered into strategic partnership, with Ferrum Health, a leading player in the AI platform market. This partnership will broaden the reach of Nanox AI’s technology for medical...Read more


Invitae and Deerfield Management Partner to Create Novel Therapeutics for Rare Diseases

March 22
Last Trade: 1.28 -0.01 -0.78

The partnership will harness genetic and clinical data from millions of patients tested at Invitae and Deerfield's expertise in drug discovery to address high unmet needs among rare disease patients  SAN FRANCISCO, March 22, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, and Deerfield Management Company, a healthcare investment firm, today announced a partnership to advance genetics-based drug...Read more


Trinity Biotech Welcomes TrinScreen HIV’s Inclusion In The New Kenyan HIV Testing Algorithm

March 22
Last Trade: 0.88 -0.06 -6.10

DUBLIN, Ireland, March 22, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today welcomed the announcement by the Kenyan Ministry of Health of the adoption of a new HIV rapid testing algorithm. This new algorithm establishes Trinity Biotech’s TrinScreen HIV as the screening test (A1 = screen test...Read more


Inspira™ Technologies Announces First in Human of HYLA™ Blood Sensor in Clinical Study

March 22
Last Trade: 1.45 0.13 9.85

First use of HYLA in a patient undergoing open-heart surgery at Sheba Medical Center in Israel RA'ANANA, Israel, March 22, 2023 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a company aiming to revolutionize acute respiratory care, has announced today the first in human of a patient undergoing open-heart surgery in the HYLA research clinical study...Read more


Helius Medical Technologies and HealthTech Connex Announce Exclusive Distribution Agreement for the Portable Neuromodulation Stimulator (PoNS®) Device

March 22
Last Trade: 0.24 -0.01 -4.12

Agreement extends existing partnership  Collaboration makes HealthTech Connex the exclusive provider of PoNS Therapy in the Vancouver area and will greatly strengthen Helius’s presence in the region  NEWTOWN, Pa., March 22, 2023 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits,...Read more


Applied DNA Sciences Submits Validation Package to New York State Department of Health for Approval of Pharmacogenomic (PGx) Assay

March 22
Last Trade: 1.13 0.07 6.60

Expansion of Population-Scale Molecular Diagnostics Menu Positions ADCL Subsidiary for Long-Term Growth STONY BROOK, N.Y. / Mar 22, 2023 / Business Wire / Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced that its wholly-owned clinical laboratory subsidiary, Applied DNA Clinical Labs, LLC (ADCL), has submitted a validation package to the New York State Department of...Read more


Aziyo Biologics and Sientra Announce SimpliDerm® Partnership to Improve Women’s Access to Biologics for Soft Tissue Reconstruction

March 22
Last Trade: 1.56 0.09 6.12

SILVER SPRING, Md. and IRVINE, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, and Sientra, Inc. (Nasdaq: SIEN) (“Sientra”), a medical aesthetics company uniquely focused on plastic surgery, today announced they have entered into an agreement to expand the...Read more


CytoSorbents Highlights New Clinical Data from Current Studies at the Live 42nd International Symposium on Intensive Care & Emergency Medicine (ISICEM)

March 22
Last Trade: 3.33 -0.07 -2.06

PRINCETON, N.J., March 22, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announced its scientific program for the 42nd International Symposium on Intensive Care & Emergency Medicine (ISICEM 2023) Congress being held this week in Brussels, Belgium.  Importantly, new data...Read more


Inogen Announces Appointment of Tom West to Board of Directors and Retirement of Board Member Kristen Miranda

GOLETA, Calif. / Mar 22, 2023 / Business Wire / Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Tom West to Inogen’s Board of Directors, effective April 1, 2023. The company also announced that Kristen Miranda, who has served as a director since March 2021, will retire as a member of the Board of Directors, effective March...Read more


Nyxoah Reports Fourth Quarter and Full Year 2022 Financial and Operating Results

March 22
Last Trade: 7.17 0.16 2.28

Completed all 115 implants in the DREAM U.S. pivotal study Mont-Saint-Guibert, Belgium – March 22, 2023 09:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the fourth quarter and full year...Read more


Sera Prognostics Reports Fourth Quarter 2022 Financial Results

March 22
Last Trade: 3.75 -0.02 -0.40

SALT LAKE CITY, March 22, 2023 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the fourth quarter and full year 2022 ended December 31, 2022. Recent Highlights: Announced positive top-line results from the AVERT PRETERM TRIAL (Serum...Read more


Aspira Women’s Health Reports Fourth Quarter and Full Year 2022 Financial Results

March 22
Last Trade: 0.37 -0.04 -9.95

2022 total revenue of $8.2 million, an increase of 20% year-over-year 2022 total OvaSuiteSM volume of 21,423 units, an increase 23% year-over-year Fourth quarter 2022 cash utilization of $7.1 million Conference Call and Webcast scheduled for today at 4:30 pm Eastern Time AUSTIN, Texas, March 22, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on...Read more


Talis Biomedical Announces Fourth Quarter and Full Year 2022 Financial Results

March 22
Last Trade: 0.49 0.0062 1.27

REDWOOD CITY, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today reported financial results for the fourth quarter and full year ended December 31, 2022. In 2022, Talis renewed its focus on the women’s and sexual health...Read more


Aziyo Biologics Reports Record Full Year 2022 Revenues

March 22
Last Trade: 1.56 0.09 6.12

SILVER SPRING, Md., March 22, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, today provided a business update and reported financial results for the fourth quarter and full year ended December 31, 2022. Business Highlights: Reported $49.2 million of net sales for full...Read more


EDAP TMS Presents Positive Results from Non-Inferiority Study Comparing Outcomes of Focal One HIFU Versus Radical Prostatectomy at EAU23

March 21
Last Trade: 11.21 -0.03 -0.27

Results demonstrate salvage treatment free survival rate (STFS) at 30 months of 90.1% in the HIFU-treated arm versus 86.8% in patients who underwent radical prostatectomy (RP) The HIFU treated arm showed significant benefits across multiple side effect and quality-of-life measures LYON, France, March 21, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), a global leader in robotic energy-based therapies, today announced a recent...Read more


Inspire Medical Systems Announces FDA Approval for Pediatric Patients with Down Syndrome

March 21
Last Trade: 248.81 0.46 0.19

MINNEAPOLIS, March 21, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today that it has received approval from the Food and Drug Administration (FDA) to offer Inspire therapy to pediatric patients with Down syndrome. “Since our...Read more


Guardant Health collaborates with The Ohio State University Comprehensive Cancer Center to study colorectal cancer screening adherence

March 21
Last Trade: 24.28 0.09 0.37

PALO ALTO, Calif. / Mar 21, 2023 / Business Wire / Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has announced support for an investigator initiated study led and conducted by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) to evaluate patient compliance with a blood-based test for colorectal cancer (CRC) screening....Read more


Dexcom: Manitoba Becomes a Provincial Trailblazer in Providing Simplified Access to Advanced Glucose Monitors

March 21
Last Trade: 116.74 2.65 2.32

BURNABY, British Columbia / Mar 21, 2023 / Business Wire / Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced that its Dexcom G6 CGM System will be available to people of all ages with type 1 and type 2 diabetes in Manitoba who meet eligibility criteria. Expanding coverage for rtCGM to include all eligible patients with type 1 or type 2 diabetes establishes...Read more


Stevanato Group Collaborates with Thermo Fisher Scientific to Bring its Innovative On-Body Delivery System Platform to Market

March 21
Last Trade: 23.18 -0.13 -0.56

PIOMBINO DESE, Italy / Mar 21, 2023 / Business Wire / Stevanato Group S.p.A. (NYSE: STVN) a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today its collaboration with Thermo Fisher Scientific, the world leader in serving science, to bring to the market a fully integrated on-body delivery system platform for subcutaneous administration. The...Read more


Invitae Announces Partnership with Epic to Streamline Genetic Testing

March 21
Last Trade: 1.28 -0.01 -0.78

Collaboration will simplify providers' and patients' access to discrete test results that can inform more precise, personalized medicine SAN FRANCISCO, March 21, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced its partnership with Epic, an industry-leading healthcare software company.  Through Aura, Epic's specialty diagnostics suite, Invitae will streamline interactions...Read more


Quest Diagnostics: First-of-Its-Kind Post-COVID-19 Panels Available at questhealth.com

March 21
Last Trade: 139.64 -0.43 -0.31

New Panels Aimed at the Millions of Americans Still Suffering From COVID-19 Side Effects SECAUCUS, N.J., March 21, 2023 /PRNewswire/ -- The consumer-initiated testing business from the leader in diagnostic testing, Quest Diagnostics (NYSE: DGX), has introduced two innovative Post-COVID-19 panels. These laboratory tests are the only comprehensive tests currently available for consumers to purchase that offer information about...Read more


Totality of Evidence from BeAT-HF Study Shows CVRx’s Barostim Provides Long-term Benefits for Patients with Heart Failure

March 21
Last Trade: 9.03 0.21 2.38

MINNEAPOLIS, March 21, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative extravascular implantable neuromodulation device for patients with cardiovascular diseases, announced detailed preliminary results of the post-market phase of the BeAT-HF trial at the second annual Technology and Heart Failure (HF)...Read more


electroCore's Truvaga Users Reported Improved Stress, Anxiety, Sleep, Energy and Mood in Recent Focus Group Study

March 21
Last Trade: 5.41 0.07 1.31

ROCKAWAY, N.J., March 21, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the results of a TruvagaTM focus group study conducted earlier this year. Based on a 30-day in-home use test by an independent third-party research firm, the Truvaga product helped its users improve stress, anxiety, sleep, energy, and mood.In the in-home focus...Read more


Nuwellis Announces Peer-Reviewed Publication of Clinical Trials Analysis Advocating the Use of Ultrafiltration for Heart Failure Patients Resistant to Diuretics

March 21
Last Trade: 4.80 -0.06 -1.23

MINNEAPOLIS, March 21, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced the peer-reviewed publication of an analysis of available ultrafiltration clinical trials with findings that support ultrafiltration as a safe and effective therapeutic option for acute decompensated heart failure (ADHF) patients who are resistant to...Read more


Precipio Ships First IV-Cell® Order to Major US Healthcare System

March 21
Last Trade: 0.65 0.0003 0.05

NEW HAVEN, Conn., March 21, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) delivered its first order of IV-Cell®, the Company’s proprietary cytogenetics cell culturing media, to a major US healthcare system. The healthcare system (unnamed for competitive reasons) has successfully completed the validation of the media and will begin the gradual incorporation into clinical use. About...Read more


ProSomnus® Receives Patent Allowance Covering Automated Manufacturing Process for Company’s Novel Precision Sleep Apnea Medical Devices

March 21
Last Trade: 5.35

PLEASANTON, Calif., March 21, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company”) (NASDAQ: OSA), a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced that the U.S. Patent and Trademark Office (USPTO) has allowed a patent application covering the Company’s proprietary automated manufacturing process for the Company’s precision medical devices; this is the third patent to issue in...Read more


Organovo Announces FXR Program

March 21
Last Trade: 2.15 0.12 5.91

SAN DIEGO, March 21, 2023 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO), a clinical stage biotechnology company that is focused on developing novel human therapies with demonstrated function in high fidelity three-dimensional (3D) tissues that recapitulate key aspects of human disease, today announced a clinical program for FXR 314, an FXR agonist that has completed initial clinical trials. FXR314 is a drug with safety and...Read more


NanoVibronix Files Provisional U.S. Patent Application for UroShield Ultra

March 21
Last Trade: 3.45 -0.20 -5.48

ELMSFORD, N.Y. / Mar 21, 2023 / Business Wire / NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (“SAW”) technology, today announced it has filed a new provisional patent application with the United States Patent and Trademark Office (“USPTO”) entitled “Multiple Frequency Surface Acoustic Waves for Internal Medical Device” (the...Read more


Neogen® Viroxide Super™ Receives New Label Claims in U.S. and Canada

March 21
Last Trade: 18.10 -0.12 -0.66

LEXINGTON, Ky., March 21, 2023 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that the U.S. Environmental Protection Agency (EPA) has approved additional virucide claims to its Neogen® Viroxide Super™ disinfectant. These label claims specify that Neogen Viroxide Super kills viruses* on hard non-porous surfaces that cause Avian Influenza A, Bovine Viral Diarrhea, Porcine Respiratory and Reproductive Syndrome (PRRS), and...Read more


NeuroMetrix to Exhibit Quell® Fibromyalgia and Present New Clinical Data at the American Academy of Pain Medicine 2023 Annual Meeting

March 21
Last Trade: 1.48 0.03 1.90

WOBURN, Mass., March 21, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) will exhibit Quell Fibromyalgia at the American Academy of Pain Medicine 39th Annual Meeting on March 23 - 26 in Ft. Lauderdale, FL. In addition, two scientific posters reporting new data on the use of Quell in patients with fibromyalgia will be presented. Fibromyalgia is a chronic condition characterized by generalized pain, fatigue, poor sleep, memory...Read more


Semler Scientific Names Wayne T. Pan, M.D., Ph.D., M.B.A. as New CEO Effective April 3, 2023

March 21
Last Trade: 25.87 0.14 0.54

SANTA CLARA, Calif., March 21, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, announces that Doug Murphy-Chutorian, M.D. has informed the board of directors of his intention to step down from his position as chief executive officer (CEO) of Semler Scientific and assist for a transition period. He will...Read more


Bruno Rossi joins Olink as Chief Commercial Officer

March 21
Last Trade: 22.43 -0.37 -1.62

UPPSALA, Sweden, March 21, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced the appointment of life sciences industry veteran Bruno Rossi to the role of Chief Commercial Officer (CCO), effective immediately. Mr. Rossi will lead the Company’s global commercial organization including Sales, Marketing and Sales Operations. He will report to Carl Raimond, President of Olink. “I am delighted to welcome...Read more


Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance

March 21
Last Trade: 2.79 0.35 14.31

Record revenue of $9.5M in 4QFY22; Increase of 208% over 4QFY21 BioXp® Revenue increased by 158% to $3.4M, in 4QFY22 over 4QFY21 SAN DIEGO, March 21, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today reported financial results for the fourth quarter and year ended December 31, 2022 and provided financial guidance for 2023. “We are grateful to our...Read more


TELA Bio Reports Fourth Quarter and Full Year 2022 Financial Results

March 21
Last Trade: 10.11 0.06 0.60

MALVERN, Pa., March 21, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy, today reported financial results for the fourth quarter and full year ended December 31, 2022. Recent Highlights Reported revenue of...Read more


Semler Scientific Reports Fourth Quarter and Full Year 2022 Financial Results

March 21
Last Trade: 25.87 0.14 0.54

2022 Q4 and Full Year highlights compared to the corresponding period of 2021: Fourth quarter revenue was $13.8 million, an increase of 20% Fourth quarter net income was $3.2 million, an increase of 113% Full year revenue was $56.7 million, an increase of 7% Full year net income was $14.3 million, a decrease of 17% Cash at December 31, 2022 increased to $43.1 million, including short-term investments Corporate update: CEO...Read more


Enzo Biochem Reports Second Quarter Fiscal Year 2023 Financial Results

March 21
Last Trade: 2.20 0.03 1.38

Company entered into an Asset Purchase Agreement for substantially all of the operating assets of the Clinical Labs division Enzo Life Sciences reports revenue of $7.5 million, with Jan-23 revenue of $3.6M as the second highest monthly revenue in over 10 years FARMINGDALE, NY, March 21, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a pioneering biosciences and diagnostics company, filed its Form 10-Q for the second quarter...Read more


LumiraDx Reports Fourth Quarter and Full Year 2022 Results

March 21
Last Trade: 0.64 0.03 4.92

LONDON, March 21, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (NASDAQ: LMDX), a next-generation point of care (POC) diagnostics company, today announced financial results for its fourth quarter and full year ended December 31, 2022. Full year 2022 revenues of $254.5 million. Q4 2022 revenue of $41.1 million compared to Q3 2022 revenue of $42.2 million; strong position in a changing COVID testing market. Increased our installed base by...Read more


Hyperfine Reports Fourth Quarter and Full Year 2022 Financial Results

March 21
Last Trade: 1.27

GUILFORD, Conn., March 21, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable MRI system™ today announced fourth quarter and full year 2022 financial results and provided a business update. “We made measurable progress at Hyperfine over the past year. We delivered $6.8 million in revenue in 2022, received multiple FDA...Read more


Predictive Oncology Reports Year End 2022 Financial Results and Provides Business Update

March 21
Last Trade: 0.29 -0.01 -3.50

EAGAN, Minn., March 21, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and enable drug development, today reported...Read more


Psychemedics Reports Fourth Quarter and Full Year 2022 Financial Results and Declares Quarterly Cash Dividend

ACTON, Mass., March 21, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, announced today fourth quarter and full year financial results for the period ended December 31, 2022. The Company also announced a quarterly cash dividend of $0.07 per share payable to shareholders of record as of March 31,2023, to be paid on April 10,2023. The Company's revenue for...Read more


Asensus Surgical Receives FDA 510(k) Clearance For Pediatric Indication for Senhance Surgical System

March 20
Last Trade: 0.62 -0.04 -5.38

RESEARCH TRIANGLE PARK, N.C., March 20, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™ (PGS), today announced that it has received 510(k) clearance from the FDA for an expanded indication to treat pediatric patients with the Senhance® System. The Senhance System is...Read more


Waters Introduces Next-Generation Alliance iS HPLC System Aimed at Reducing Up to 40% of Common Lab Errors

March 20
Last Trade: 301.29 1.33 0.44

PHILADELPHIA / Mar 20, 2023 / Business Wire / PITTCON 2023 – Waters Corporation (NYSE:WAT) today introduced Alliance iS, the next-generation intelligent HPLC System, designed to reduce compliance risk by adding new levels of proactive error detection, troubleshooting and ease-of-use. When combined with Waters’ compliance-ready Empower Chromatography Software and eConnect™ HPLC Columns, the Alliance iS High Performance Liquid Chromatography...Read more


Merit Medical Launches Expanded SwiftNINJA® Steerable Microcatheter Offering

March 20
Last Trade: 72.23 0.15 0.21

SOUTH JORDAN, Utah, March 20, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the expansion of its SwiftNINJA Steerable Microcatheter product line. New sizes include a low-profile 2.4F distal diameter option in 125-cm and new longer 150-cm lengths. The 180-degree articulating microcatheter is designed to provide access to challenging...Read more


NuVasive Specialized Orthopedics Expands Indications of Precice Limb Lengthening System to Treat Pediatric Patients

March 20
Last Trade: 38.22 1.14 3.07

SAN DIEGO, March 20, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the use of its Precice all-internal limb lengthening solution to include pediatric patients*. The expanded clearance...Read more


Quest Diagnostics Completes Acquisition of Northern Light Laboratory in Maine

March 20
Last Trade: 139.64 -0.43 -0.31

SECAUCUS, N.J., March 20, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced it has completed its previously announced acquisition of select assets of Northern Light Laboratory, the outreach laboratory services business of Northern Light Health, a large integrated healthcare system in Maine. The collaboration between the two parties is expected to enable...Read more


Henry Schein One Announces Availability of AI Solutions for Dentrix Ascend

March 20
Last Trade: 79.70 0.53 0.67

AMERICAN FORK, Utah / Mar 20, 2023 / Business Wire / Henry Schein One, a joint venture of Henry Schein Inc. and Internet Brands, has reinforced their commitment to helping dental practices harness the power of Artificial Intelligence (AI) by fully integrating AI solutions into Dentrix Ascend, the Company’s cloud-based practice management software. These solutions include Dentrix® Ascend Detect AI powered and manufactured by VideaHealth, and...Read more


Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum

March 20
Last Trade: 34.82 0.30 0.87

MORRISVILLE, N.C., March 20, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic multi-year agreement with Microsoft. Utilizing Microsoft Azure services, Syneos Health has developed an advanced analytics platform that enables agile deployment of machine learning (ML) supporting the analysis, design and execution of clinical trials and...Read more


Surgalign Launches Next Generation Software for its HOLO Portal™ Surgical Guidance System and Expands Surgical Tool Integration to Drive Use Case Adoption

March 20
Last Trade: 1.69 0.01 0.60

DEERFIELD, Ill., March 20, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced the first major upgrade of the HOLO Portal™ Surgical Guidance System since the first case was performed in May of 2022. Since launch, the Company has worked with surgeons to enhance system functionality and...Read more


IMAC Holdings and Brain Scientific Announce a Strategic Merger to Create Synergistic End-To-End Neurological Solution

BRENTWOOD, Tenn. and LAKEWOOD RANCH, Fla., March 20, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- IMAC Holdings, Inc. (“IMAC”) (Nasdaq: BACK), a regenerative rehabilitation company focused on treating musculoskeletal and neurodegenerative disease, and Brain Scientific, Inc. (“Brain Scientific”) (OTCQB:BRSF), a Florida-based applied science technology company, jointly announced today that they have executed a binding Letter of Intent...Read more


Stereotaxis: Broward Health Medical Center the First Hospital in Florida Using Advanced Genesis Robotic Technology to Treat Heart Rhythm Disorders

March 20
Last Trade: 1.87 0.02 0.81

ST. LOUIS, March 20, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced the grand opening of a new robotic electrophysiology program at Broward Health Medical Center in Fort Lauderdale, Florida. Broward Health is among the first in the nation, and the first in Florida, to offer the latest Genesis Robotic Magnetic Navigation...Read more


Sign Up To Get Daily Health Stock News

Please review our Disclaimer and Privacy Policy before subscribing.

Today's Medical Gainers

 
CompanyChangeLast Trade
Mettler-Toledo 9.36 0.64 $1,469.11
Repligen 6.72 4.19 $166.98
Bio-Rad Laboratories 5.20 1.13 $465.98
Thermo Fisher Scientific 4.56 0.82 $562.82
CONMED 4.18 4.31 $101.18
Teleflex 4.00 1.61 $252.94
ResMed 3.24 1.52 $215.83
DexCom 2.65 2.32 $116.74
West Pharmaceutical 2.50 0.75 $336.80
IDEXX Laboratories 2.30 0.47 $487.81
Becton Dickinson 2.29 0.95 $242.79
ShockWave Medical 2.25 1.05 $216.49
Penumbra 2.20 0.80 $276.87
Stryker 2.19 0.79 $278.88
McKesson 2.00 0.58 $348.56

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

COPYRIGHT ©2023 HEALTH STOCKS HUB